Developer docs
API playgroundTry for free, no card

Search company profiles

Stanmore Implants Worldwide

Full company profile

uuid000xfl3

Namestring
Stanmore Implants Worldwide
Company typeenum
Private
Founded yearint
1948
Descriptiontext

Stanmore Implants Worldwide is a UK-based, privately held medical device company founded in 1948 and headquartered in Elstree. It develops bespoke and modular orthopaedic implants for limb-sparing surgery and for complex primary and revision joint replacement, addressing clinical cases where off-the-shelf implants are inadequate. The company operates with a workforce of 101–250 employees, indicating a mid-sized specialty manufacturer rather than a mass-market orthopaedic producer.

Its product portfolio is centred on custom and modular implant systems, and the company appears to monetise these through direct sales to specialist surgical centres, tertiary hospitals and orthopaedic oncology units performing complex reconstructions. Bespoke implants are inherently case-by-case manufactured, which limits unit volumes but supports a project-based revenue model tied to clinician engagement, pre-operative planning services and instrument sets rather than high-volume catalogue sales.

Operationally, the company has been sustained by a series of venture financings — approximately $33.8M disclosed across three rounds between 2008 and 2013 — from specialist healthcare investors including Abingworth, MDY Healthcare, Imperial Innovations and Norgine Ventures. It also executed a single disclosed acquisition in October 2010. The combination of long operating history (since 1948), a niche high-complexity clinical focus, and steady specialist-VC backing is consistent with a steady-state specialty medical device business rather than a high-growth scale play.

Short descriptiontext

UK-based medical device company developing bespoke and modular orthopaedic implants for limb-sparing surgery and complex primary and revision joint replacement, serving specialist surgical centres and tertiary hospitals performing complex reconstructions.

Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersElstree, United Kingdom
HQ citystring
Elstree
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
orthopaedic implants, joint replacement, limb sparing, bespoke implants, revision arthroplasty
Industry3 codes
PRIMARYHLAHAEAJ
3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLAHAEAB
Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLAHAEAA
Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
NAICS code2 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Surgical & Medical Instruments & Apparatus3841
Product category
Orthopaedic Implants
Cost components5 values
Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Stanmore Implants Worldwide develops bespoke and modular orthopaedic implants used in limb-sparing surgical procedures and in complex primary and revision joint replacement surgeries. The company manufactures patient-specific and modular implant systems intended for orthopaedic surgeons treating severe bone loss, oncology cases, and complex revision arthroplasty that cannot be addressed with standard off-the-shelf implants.

Differentiator
Functional benefit
Problem solved
Product and service4 records
1Bespoke Patient-Specific Implants
2Modular Limb-Sparing Implants
3Complex Primary Joint Replacement Implants
4Revision Joint Replacement Implants
Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global leader in orthopedic reconstruction (hips, knees, extremities) and one of Stanmore's primary competitors in primary and revision joint replacement, with growing investments in patient-specific and 3D-printed implants.

TypeBroad incumbent
Description

Major orthopedic and trauma franchise within J&J covering joint reconstruction, trauma, and extremities. Competes with Stanmore in complex joint replacement and limb-sparing surgery via ATTUNE and trauma/extremities lines.

TypeBroad incumbent
Description

One of the world's largest orthopedic medical technology companies with extensive joint replacement, trauma, and patient-specific implant lines (e.g., Mako). Comparable to Stanmore as a competitor in orthopedic reconstruction but at vastly larger scale and broader portfolio.

TypeBroad incumbent
Description

UK-headquartered global medical device company with orthopedic reconstruction, trauma, and sports medicine portfolios. Directly comparable as a UK-based peer competing in joint replacement and bespoke implant niches.

TypeDirect peer
Description

Specializes in individually manufactured, patient-specific knee replacement implants using 3D printing and CT-based customization—the closest direct analog to Stanmore's bespoke implant model, albeit focused on knee rather than limb-sparing and complex revision.

TypeDirect peer
Description

Germany-based orthopedic implant manufacturer with a strong tumor/limb-sparing prosthesis and revision reconstruction portfolio. Direct competitor in the bespoke oncology and modular revision segment.

7Adler Ortho (LimaCorporate-adjacent)
TypeRegional player
Description

Italian/European orthopedic implant maker historically focused on hip prostheses, now part of the LimaCorporate ecosystem. Comparable as a regional European specialist competing in primary and revision hip implants.

TypeDirect peer
Description

Focused on personalized orthopedic oncology and complex revision implants, including 3D-printed patient-specific devices for tumor and limb-sparing cases. Strongly comparable given its near-identical niche to Stanmore's limb-sparing focus.

TypeDirect peer
Description

German manufacturer specializing in revision hip and knee implants, modular systems, and tumor/oncology prostheses. Directly comparable to Stanmore in modular and complex revision joint replacement implants.

TypeDirect peer
Description

UK-headquartered orthopedic implant company offering hip, knee, and shoulder reconstruction solutions with emphasis on connected implant technology and personalized solutions. Comparable as a mid-sized UK/European specialist.

Market position
Strengths1 record

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Stanmore Implants Worldwide

Orthopaedic Implantsstanmoreimplants.com

UK-based medical device company developing bespoke and modular orthopaedic implants for limb-sparing surgery and complex primary and revision joint replacement, serving specialist surgical centres and tertiary hospitals performing complex reconstructions.

What Stanmore Implants Worldwide does

Stanmore Implants Worldwide is a UK-based, privately held medical device company founded in 1948 and headquartered in Elstree. It develops bespoke and modular orthopaedic implants for limb-sparing surgery and for complex primary and revision joint replacement, addressing clinical cases where off-the-shelf implants are inadequate. The company operates with a workforce of 101–250 employees, indicating a mid-sized specialty manufacturer rather than a mass-market orthopaedic producer.

Its product portfolio is centred on custom and modular implant systems, and the company appears to monetise these through direct sales to specialist surgical centres, tertiary hospitals and orthopaedic oncology units performing complex reconstructions. Bespoke implants are inherently case-by-case manufactured, which limits unit volumes but supports a project-based revenue model tied to clinician engagement, pre-operative planning services and instrument sets rather than high-volume catalogue sales.

Operationally, the company has been sustained by a series of venture financings — approximately $33.8M disclosed across three rounds between 2008 and 2013 — from specialist healthcare investors including Abingworth, MDY Healthcare, Imperial Innovations and Norgine Ventures. It also executed a single disclosed acquisition in October 2010. The combination of long operating history (since 1948), a niche high-complexity clinical focus, and steady specialist-VC backing is consistent with a steady-state specialty medical device business rather than a high-growth scale play.

Stanmore Implants Worldwide firmographics

Firmographics
Name
Stanmore Implants Worldwide
Website
https://stanmoreimplants.com
Company type
Private
Founded year
1948
Headcount range
11–50 employees
Short description
UK-based medical device company developing bespoke and modular orthopaedic implants for limb-sparing surgery and complex primary and revision joint replacement, serving specialist surgical centres and tertiary hospitals performing complex reconstructions.
Ownership category
akta.pro rank

Stanmore Implants Worldwide industry classification

Industry
Product category
Orthopaedic Implants
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHAEAJ
3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLAHAEAB
Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLAHAEAA
Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)

Keywords

  • Orthopaedic implants
  • Joint replacement
  • Limb sparing
  • Bespoke implants
  • Revision arthroplasty

Where Stanmore Implants Worldwide is headquartered

Location

Headquarters

HQ city
Elstree
HQ country
United Kingdom
HQ region
Europe

Markets served

Stanmore Implants Worldwide business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales

Stanmore Implants Worldwide product offering

Product offering

Core offering

Stanmore Implants Worldwide develops bespoke and modular orthopaedic implants used in limb-sparing surgical procedures and in complex primary and revision joint replacement surgeries. The company manufactures patient-specific and modular implant systems intended for orthopaedic surgeons treating severe bone loss, oncology cases, and complex revision arthroplasty that cannot be addressed with standard off-the-shelf implants.

Differentiator

Problem solved

Functional benefit

Products and services

  • Bespoke Patient-Specific Implants
  • Modular Limb-Sparing Implants
  • Complex Primary Joint Replacement Implants
  • Revision Joint Replacement Implants

Companies that use Stanmore Implants Worldwide

Customer profile

Ideal customer profiles1 record

Stanmore Implants Worldwide technology and API

Technology

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Stanmore Implants Worldwide partnerships and signals

Strategic signal

Recent moves4 records

Expansion highlights3 records

Stanmore Implants Worldwide competitors and assessment

Company assessment

Broad incumbents

  • Zimmer Biomet: Global leader in orthopedic reconstruction (hips, knees, extremities) and one of Stanmore's primary competitors in primary and revision joint replacement, with growing investments in patient-specific and 3D-printed implants.
  • DePuy Synthes (Johnson & Johnson MedTech): Major orthopedic and trauma franchise within J&J covering joint reconstruction, trauma, and extremities. Competes with Stanmore in complex joint replacement and limb-sparing surgery via ATTUNE and trauma/extremities lines.
  • Stryker: One of the world's largest orthopedic medical technology companies with extensive joint replacement, trauma, and patient-specific implant lines (e.g., Mako). Comparable to Stanmore as a competitor in orthopedic reconstruction but at vastly larger scale and broader portfolio.
  • Smith+Nephew: UK-headquartered global medical device company with orthopedic reconstruction, trauma, and sports medicine portfolios. Directly comparable as a UK-based peer competing in joint replacement and bespoke implant niches.

Direct peers

  • Conformis: Specializes in individually manufactured, patient-specific knee replacement implants using 3D printing and CT-based customization—the closest direct analog to Stanmore's bespoke implant model, albeit focused on knee rather than limb-sparing and complex revision.
  • Implantcast: Germany-based orthopedic implant manufacturer with a strong tumor/limb-sparing prosthesis and revision reconstruction portfolio. Direct competitor in the bespoke oncology and modular revision segment.
  • Onkos Surgical: Focused on personalized orthopedic oncology and complex revision implants, including 3D-printed patient-specific devices for tumor and limb-sparing cases. Strongly comparable given its near-identical niche to Stanmore's limb-sparing focus.
  • Waldemar Link: German manufacturer specializing in revision hip and knee implants, modular systems, and tumor/oncology prostheses. Directly comparable to Stanmore in modular and complex revision joint replacement implants.
  • Corin: UK-headquartered orthopedic implant company offering hip, knee, and shoulder reconstruction solutions with emphasis on connected implant technology and personalized solutions. Comparable as a mid-sized UK/European specialist.

Regional players

  • Adler Ortho (LimaCorporate-adjacent): Italian/European orthopedic implant maker historically focused on hip prostheses, now part of the LimaCorporate ecosystem. Comparable as a regional European specialist competing in primary and revision hip implants.

Market position

Strengths1 record

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights5 records

Customer concentration

Stanmore Implants Worldwide social profiles

Digital presence

Stanmore Implants Worldwide financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Stanmore Implants Worldwide leadership team

Management profile

Number of profiles

Stanmore Implants Worldwide funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Stanmore Implants Worldwide M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Stanmore Implants Worldwide

What does Stanmore Implants Worldwide do?

Stanmore Implants Worldwide develops bespoke and modular orthopaedic implants used in limb-sparing surgical procedures and in complex primary and revision joint replacement surgeries. The company manufactures patient-specific and modular implant systems intended for orthopaedic surgeons treating severe bone loss, oncology cases, and complex revision arthroplasty that cannot be addressed with standard off-the-shelf implants.

When was Stanmore Implants Worldwide founded?

Stanmore Implants Worldwide was founded in 1948. It employs 11 to 50 people.

Where is Stanmore Implants Worldwide based?

Stanmore Implants Worldwide is headquartered in Elstree, United Kingdom, in the Europe region.

Who are Stanmore Implants Worldwide's main competitors?

Broad incumbents on record are Zimmer Biomet, DePuy Synthes (Johnson & Johnson MedTech), Stryker and Smith+Nephew. Direct peers are Conformis, Implantcast, Onkos Surgical, Waldemar Link and Corin. Adler Ortho (LimaCorporate-adjacent) is listed as a regional player.

Does Stanmore Implants Worldwide have an API?

No public API is recorded for Stanmore Implants Worldwide.

What industry is Stanmore Implants Worldwide in?

Stanmore Implants Worldwide's product category is Orthopaedic Implants. Its primary akta.pro industry code is HLAHAEAJ, 3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial), with a secondary code of HLAHAEAB, Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation). Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireBiological Implants Market Size And Forecast By Product (Autografts, Allografts, Xenografts), By Application (Cardiovascular Orthopedic, Dental, & Dermal Implants), By Mode Of Administration (InjectabA new report by Grand View Research, Inc. anticipates the global biological implant market will reach USD 9.8 billion by 2024, driven by increased adoption of grafts for reconstructive surgeries. The Asia Pacific region is projected to exhibit the fastest growth due to improving healthcare infrastructure, while North America currently dominates with a 50% revenue share. Key industry players are pursuing strategies such as novel product development and acquisitions, exemplified by Stryker Corporation's acquisition of Stanmore Implants Worldwide Limited.GlobeNewswireStryker acquires Stanmore Implants Worldwide LimitedStryker Corporation acquired Stanmore Implants Worldwide Limited from SIW Holdings in an all-cash deal for £35.6 million. The acquisition adds orthopaedic oncology implant systems for limb salvage, expanding Stryker's global presence in that market.GlobeNewswireMAKO Surgical Corp. and Stanmore Implants Worldwide Ltd. Announce MAKO's Purchase of Stanmore Sculptor Robotic Guidance ArmMAKO Surgical Corp. agreed to settle all patent infringement actions against Stanmore Implants and acquire Stanmore's Sculptor Robotic Guidance Arm assets. In exchange for a cash payment, MAKO will withdraw its legal actions and receive Stanmore's robotic business assets and intellectual property, while Stanmore will withdraw from robotics.FinSMEsStanmore Implants Receives £4m Equity Investment from Imperial Innovations Group - FinSMEsStanmore Implants received a £4m equity investment from Imperial Innovations Group. The funds will expand US and UK sales and develop new implant technologies, including the Savile Row System and ITAP. John Holden joined the board as non-executive director.